Summary
Lysinuric protein intolerance (LPI) is an autosomal recessive disease characterized by defective transport of cationic amino acids. Patients have an increased incidence of fractures and their skeletal radiographs show osteoporosis. The aim of the study was to characterize the osteopenia in LPI.
Twenty-nine Finnish LPI patients (age range 3.7–44.4 years) were screened for parameters of bone metabolism. Morphometric analysis of bone was carried out in specimens of 9 patients. Collagen synthesis was studied with cultured skin fibroblasts (4 patients) and collagen fibril sizes (3 patients) were measured using electron microscopy.
Most histological bone specimens (8/9) showed osteoporosis. Osteomalacia was excluded. Routine clinical laboratory tests were unrevealing. The concentrations of free hydroxyproline and type III procollagen N-propeptide in serum and the urinary excretion of hydroxyproline were increased in almost all patients during their growth and in about half of adult patients. Collagen synthesis in LPI fibroblast cultures was significantly decreased compared with that in age-matched controls at 5 (p<0.01), 14 (p<0.01) and still at 30 years (p<0.01), whereas no difference was observed at the age of 44 years (p=N.S.).
Osteoporosis in LPI might reflect defective matrix protein synthesis caused by protein deprivation and deficiency of cationic amino acids. Increased collagen turnover can also contribute to the osteoporosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bentsen KD, Henriksen JH, Bendtsen F, Horslev-Petersen K, Lorenzen I (1990) Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic liver disease.Hepatology 11: 957–963.
Boskey AL (1990) Bone mineral and matrix.Orthop Clin N Am 21: 19–29.
Brody LC, Mitchell GA, Obie C et al (1992) Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences.J Biol Chem 15: 3302–3307.
Carpenter TO, Levy HL, Holtrop ME, Shih VE, Anast CS (1985) Lysinuric protein intolerance presenting as childhood osteoporosis.N Engl J Med 31: 290–294.
Chen T (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.Exp Cell Res 104: 255–262.
Consensus development conference: prophylaxis and treatment of osteoporosis. Conference report (1991)Am J Med 90: 107–110.
Epstein S (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover.Endocrine Rev 9: 437–449.
Fouser L, Sage EH, Clark J, Bornstein P (1991) Feedback regulation of collagen gene expression: A Trojan horse approach.Proc Natl Acad Sci USA 88: 10158–10162.
Gasser A, Celada A, Courvoisier B et al (1979) The clinical measurement of urinary total hydroxyproline excretion.Clin Chim Acta 95: 487–491.
Gevers G, Dequeker J (1987) Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis.Collagen Rel Res 7: 435–442.
Hoikka V, Arnala I (1981) Histomorphometric normal values of the iliac crest cancellous bone in a Finnish autopsy series.Ann Clin Res 13: 383–386.
Holbrook KA, Byers PM (1982) Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders.J Invest Dermatol 79: 7–16.
Jha GH, Deo MG, Ramalingaswami V (1968) Bone growth in protein deficiency, a study in rhesus monkeys.Am J Pathol 53: 1111–1121.
Jimenez SA (1991) Molecular biological approaches to the study of heritable osteoarthritis.J Rheumatol 18: 7–9.
Juva K, Prockop DJ (1966) Modified procedure for the assay of H3-or C14-labeled hydroxyproline.Anal Biochem 15: 77–83.
Kuivaniemi H, Tromp G, Prockop DJ (1991) Mutations in collagen genes: Causes of rare and some common diseases in humans.F ASEB J 5: 2052–2060.
Likins RC, Bavetta LA, Posner AS (1957) Calcification in lysine deficiency.Arch Biochem Biophys 70: 401–412.
Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.Clin Chem 36: 1328–1332.
Minnisola S, Antonelli R, Mazzuoli G (1985) Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.J Clin Chem Clin Biochem 23: 515–519.
Mizutani N, Kato T, Maehara M, Watanabe K, Ban M (1984) Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance.Tohuko J Exp Med 142: 15–24.
Näntö-Salonen K, Penttinen R (1982) Metabolism of collagen in aspartylglycosaminuria: Decreased synthesis by cultured fibroblasts.J Inher Metab Dis 5: 197–203.
Perheentupa J, Simell O (1974) Lysinuric protein intolerance.Birth Defects 10: 201–207.
Pihlajaniemi T, Myllylä R, Kivirikko K (1991) Prolyl-4-hydroxylase and its role in collagen synthesis.J Hepatol 13 (Suppl.): 2–7.
Prockop DJ, Kivirikko KJ (1984) Heritable diseases of collagen.N Engl J Med 9: 376–386.
Rajantie J, Simell O, Rapola J, Perheentupa J (1980) Lysinuric protein intolerance: A two-year trial of dietary supplementation therapy with citrulline and lysine.J Pediatr 97: 927–932.
Rajantie J, Simell O, Perheentupa J (1981) Lysinuric protein intolerance: basolateral transport defect in renal tubuli.J Clin Invest 67: 1078–1082.
Rigotti N, Nussbaum S, Herzog D, Neer R (1984) Osteoporosis in women with anorexia nervosa.N Engl J Med 311: 1601–1606.
Risteli L, Risteli J (1990) Noninvasive methods for detection of organ fibrosis. In Rojkind M, ed.Focus on Connective Tissue in Health and Disease. Boca Raton: CRC Press, 61–98.
Robey PG (1989) The biochemistry of bone.Endocrin Metab N Am 18: 859–891.
Shieres R, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1980) Effects of semistarvation on skeletal homeostasis.Endocrinol 107: 1530–1535.
Simell O (1989) Lysinuric protein intolerance and other cationic aminoacidurias. In Scriver C, Beaudet AL, Sly W and Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. McGraw-Hill, New York, 2497–2513.
Simell O, Perheentupa J, Rapola J, Visakorpi J, Eskelin L (1975) Lysinuric protein intolerance.Am J Med 59: 229–240.
Smedsröd B (1988) Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells.Collagen Rel Res 8: 375–388.
Svedström E, Parto K, Marttinen M, Virtama P, Simell O (1993) Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.Skeletal Radiol 22: 11–16.
Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CGD (1989) Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.J Pediatr 114: 225–230.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parto, K., Penttinen, R., Paronen, I. et al. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis 16, 441–450 (1993). https://doi.org/10.1007/BF00710296
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00710296